Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Multiple sclerosis--the plaque and its pathogenesis.

Frohman EM, Racke MK, Raine CS.

N Engl J Med. 2006 Mar 2;354(9):942-55. Review. No abstract available.

PMID:
16510748
2.

The pathogenesis and basis for treatment in multiple sclerosis.

Compston A.

Clin Neurol Neurosurg. 2004 Jun;106(3):246-8.

PMID:
15177777
3.

The neuropathology of multiple sclerosis.

Ludwin SK.

Neuroimaging Clin N Am. 2000 Nov;10(4):625-48 ,vii. Review.

PMID:
11359716
4.

Neuronal degeneration in a viral model of multiple sclerosis.

Schneider R.

J Neurosci. 2009 Dec 9;29(49):15353-4. doi: 10.1523/JNEUROSCI.5198-09.2009. No abstract available.

5.

Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

Lassmann H, Suchanek G, Ozawa K.

Ann Neurol. 1994;36 Suppl:S42-6.

PMID:
8017888
6.

Axon reactions precede demyelination in experimental models of multiple sclerosis.

Zapryanova E, Sotnikov OS, Sergeeva SS, Deleva D, Filchev A, Sultanov B.

Neurosci Behav Physiol. 2004 May;34(4):337-42. No abstract available.

PMID:
15341209
7.

A real-time insight into disease progression and the role of axonal injury in multiple sclerosis.

Bjartmar C, Kidd G, Ransohoff RM.

Arch Neurol. 2001 Jan;58(1):37-9. No abstract available.

PMID:
11176934
8.

Axonal damage in multiple sclerosis: a complex issue in a complex disease.

Grigoriadis N, Ben-Hur T, Karussis D, Milonas I.

Clin Neurol Neurosurg. 2004 Jun;106(3):211-7. Review.

PMID:
15177770
9.

Immunologic aspects of multiple sclerosis.

Boppana S, Huang H, Ito K, Dhib-Jalbut S.

Mt Sinai J Med. 2011 Mar-Apr;78(2):207-20. doi: 10.1002/msj.20249.

PMID:
21425265
10.

Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.

Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, Freedman MS, Atkins HL, Azzarelli B, Kolar OJ, Brück W.

Brain. 2007 May;130(Pt 5):1254-62. Epub 2007 Feb 9.

PMID:
17293360
12.

The pathology of multiple sclerosis and its evolution.

Lassmann H.

Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1635-40. Review.

13.

Some spaces and barriers in postmortem multiple sclerosis.

Tourtellotte WW, Parker JA.

Prog Brain Res. 1968;29:493-525. No abstract available.

PMID:
5735306
14.
15.

Demyelinating diseases--new pathological insights, new therapeutic targets.

Waxman SG.

N Engl J Med. 1998 Jan 29;338(5):323-5. No abstract available.

PMID:
9445415
16.

Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.

Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.

Glia. 2005 Aug 15;51(3):235-40.

PMID:
15812814
17.

Multiple sclerosis - candidate mechanisms underlying CNS atrophy.

Siffrin V, Vogt J, Radbruch H, Nitsch R, Zipp F.

Trends Neurosci. 2010 Apr;33(4):202-10. doi: 10.1016/j.tins.2010.01.002. Epub 2010 Feb 12. Review.

PMID:
20153532
18.
19.

[Multiple sclerosis. Current status of research. II].

Lhermitte F, Lyon-Caen O.

Rev Neurol (Paris). 1983;139(6-7):395-406. French. No abstract available.

PMID:
6612147
20.

The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis.

Rodriguez M, Rivera-Quinones C, Murray PD, Kariuki Njenga M, Wettstein PJ, Mak T.

J Neurovirol. 1997 May;3 Suppl 1:S43-5. No abstract available.

PMID:
9179791

Supplemental Content

Support Center